Evidence mapPaperPMID 16933967Full record

SynthesisPLoS medicine2006

Statins in the treatment of chronic heart failure: a systematic review.

Pim van der Harst, Adriaan A Voors, Wiek H van Gilst, Michael Böhm, Dirk J van Veldhuisen

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in PLoS medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Statins in heart failure: do we need another trial?Vascular health and risk management · 2013
    Review
  5. Review
  6. Aging, telomeres and heart failure.Heart failure reviews · 2010
    Review
  7. Telomere biology in healthy aging and disease.Pflugers Archiv : European journal of physiology · 2010
    Review
  8. Article
  9. Review
  10. The case for statin therapy in chronic heart failure.Clinical research in cardiology : official journal of the German Cardiac Society · 2008
    Review
  11. Beta blockers and glucose metabolism in chronic heart failure: friend or foe?Clinical research in cardiology : official journal of the German Cardiac Society · 2008
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Pim van der HarstDepartment of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, Netherlands. p.van.der.harst@thorax.azg.nl
Adriaan A Voors
Wiek H van Gilst
Michael Böhm
Dirk J van Veldhuisen
University Medical Center Groningen · NLSaarland University · DEThorax Foundation · GRUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe efficacy of statin therapy in patients with established chronic heart failure (CHF) is a subject of much debate. METHODS AND

findingsWe conducted three systematic literature searches to assess the evidence supporting the prescription of statins in CHF. First, we investigated the participation of CHF patients in randomized placebo-controlled clinical trials designed to evaluate the efficacy of statins in reducing major cardiovascular events and mortality. Second, we assessed the association between serum cholesterol and outcome in CHF. Finally, we evaluated the ability of statin treatment to modify surrogate endpoint parameters in CHF. Using validated search strategies, we systematically searched PubMed for our three queries. In addition, we searched the reference lists from eligible studies, used the "see related articles" feature for key publications in PubMed, consulted the Cochrane Library, and searched the ISI Web of Knowledge for papers citing key publications. Search 1 resulted in the retrieval of 47 placebo-controlled clinical statin trials involving more than 100,000 patients. CHF patients had, however, been systematically excluded from these trials. Search 2 resulted in the retrieval of eight studies assessing the relationship between cholesterol levels and outcome in CHF patients. Lower serum cholesterol was consistently associated with increased mortality. Search 3 resulted in the retrieval of 18 studies on the efficacy of statin treatment in CHF. On the whole, these studies reported favorable outcomes for almost all surrogate endpoints.

conclusionsSince CHF patients have been systematically excluded from randomized, controlled clinical cholesterol-lowering trials, the effect of statin therapy in these patients remains to be established. Currently, two large, randomized, placebo-controlled statin trials are under way to evaluate the efficacy of statin treatment in terms of reducing clinical endpoints in CHF patients in particular.

Indexed as

Anticholesteremic AgentsCholesterolHeart FailureHumansMeta-Analysis as TopicRandomized Controlled Trials as TopicAnticholesteremic AgentsCholesterol

Identifiers

PMID16933967
PMCPMC1551909
OpenAlexW2162507582

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.